Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ocumetics Technology Corp V.OTC

Alternate Symbol(s):  OTCFF

Ocumetics Technology Corp. is a Canada-based research and product development company. The Company specializes in adaptive lens designs. It is in the preclinical study stage of development of an intraocular lens. It is focused on developing intraocular lenses for people over 45 years of age. The Ocumetics lens, which is an expandable intraocular lens that fits within the natural lens compartment of the eye to eliminate the need for corrective lenses. It is designed to allow the eye’s natural muscle activity to shift focus from distance to nearby. The Lens consists of self-adapting suspension systems that modulate curvature change. The Lens’s suspension systems are comprised of cushions that are designed to conform to unique parameters of each recipient’s eye. When ciliary muscles relax, during sleep or when the eye focuses upon distant objects, the optical interface is compressed into its high energy state by expansion of the suspension system.


TSXV:OTC - Post by User

Comment by HeavyLincolnon Jul 25, 2022 11:04pm
159 Views
Post# 34849991

RE:Progress!

RE:Progress!This is going to be a very exciting company to watch and support as an investor...(especially when Ocumetics restores my eyesight!). IMHO, this really is as close to "ground floor" as you can get! This next year is going to be quite interesting as they advance testing. I just recently started purchasing shares and will continue throughout the rest of the year. Based on their own "Roadmap" outlined in their Investor Presentation, specifically on page 34, significant growth and shareholder value could be realized by 2026/27. I think this company's success is much closer to realization than anyone really understands. I think this is why trading volume is low and the conversation is thin... it won't be long though.
<< Previous
Bullboard Posts
Next >>